Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis

被引:62
|
作者
Mayer-Hamblett, Nicole [1 ,2 ,6 ]
Ramsey, Bonnie W. [1 ,6 ]
Kulasekara, Hemantha D. [3 ]
Wolter, Daniel J. [1 ]
Houston, Laura S. [1 ]
Pope, Christopher E. [1 ]
Kulasekara, Bridget R. [3 ]
Armbruster, Catherine R. [3 ]
Burns, Jane L. [1 ,6 ]
Retsch-Bogart, George [7 ]
Rosenfeld, Margaret [1 ,6 ]
Gibson, Ronald L. [1 ,6 ]
Miller, Samuel I. [3 ,4 ,5 ]
Khan, Umer [6 ]
Hoffman, Lucas R. [1 ,3 ,6 ]
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98105 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA
[5] Univ Washington, Dept Med, Seattle, WA 98105 USA
[6] Seattle Childrens Hosp, Washington, DC USA
[7] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
cystic fibrosis; Pseudomonas aeruginosa; phenotypic characterization; eradication; antibiotic treatment; YOUNG-CHILDREN; COLONY MORPHOLOGY; LUNG-FUNCTION; LASR MUTANTS; INFECTION; ADAPTATION; TOBRAMYCIN; DISEASE; AIRWAYS; DIVERSIFICATION;
D O I
10.1093/cid/ciu385
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF). Due to its association with lung disease progression, initial detection of P. aeruginosa in CF respiratory cultures usually results in antibiotic treatment with the goal of eradication. Pseudomonas aeruginosa exhibits many different phenotypes in vitro that could serve as useful prognostic markers, but the relative relationships between these phenotypes and failure to eradicate P. aeruginosa have not been well characterized. Methods. We measured 22 easily assayed in vitro phenotypes among the baseline P. aeruginosa isolates collected from 194 participants in the 18-month EPIC clinical trial, which assessed outcomes after antibiotic eradication therapy for newly identified P. aeruginosa. We then evaluated the associations between these baseline isolate phenotypes and subsequent outcomes during the trial, including failure to eradicate after antipseudomonal therapy, emergence of mucoidy, and occurrence of an exacerbation. Results. Baseline P. aeruginosa isolates frequently exhibited phenotypes thought to represent chronic adaptation, including mucoidy. Wrinkly colony surface and irregular colony edges were both associated with increased risk of eradication failure (hazard ratios [95% confidence intervals], 1.99 [1.03-3.83] and 2.14 [1.32-3.47], respectively). Phenotypes reflecting defective quorum sensing were significantly associated with subsequent mucoidy, but no phenotype was significantly associated with subsequent exacerbations during the trial. Conclusions. Pseudomonas aeruginosa phenotypes commonly considered to reflect chronic adaptation were observed frequently among isolates at early detection. We found that 2 easily assayed colony phenotypes were associated with failure to eradicate after antipseudomonal therapy, both of which have been previously associated with altered biofilm formation and defective quorum sensing.
引用
收藏
页码:624 / 631
页数:8
相关论文
共 50 条
  • [31] Comparative efficacy of two doses of nebulized colistimethate for the eradication of Pseudomonas aeruginosa in children with cystic fibrosis
    Brochet, Marie-Sophie
    McDuff, Anne-Catherine
    Bussieres, Jean-Francois
    Caron, Elaine
    Fortin, Genevieve
    Lebel, Denis
    Marcotte, Jacques-Edouard
    CANADIAN RESPIRATORY JOURNAL, 2007, 14 (08) : 473 - 479
  • [32] ERADICATION OF PSEUDOMONAS AERUGINOSA IN PEDIATRIC PATIENTS WITH CYSTIC FIBROSIS: A COMPARISON OF PROTOCOLS
    Searcy, H.
    Phillips, S.
    Benner, K.
    Britton, L. J.
    Harris, W. T.
    Hoover, W.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 347 - 347
  • [33] ERADICATION OF MUCOID PSEUDOMONAS AERUGINOSA IN PATIENTS WITH CYSTIC FIBROSIS: A RETROSPECTIVE ANALYSIS
    Troxler, R. B.
    Hoover, W. C.
    Britton, L. J.
    Gerwin, A. M.
    Rowe, S. M.
    PEDIATRIC PULMONOLOGY, 2009, : 327 - 327
  • [34] Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    Döring, G
    EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) : 458 - 461
  • [35] The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis
    Emiralioglu, N.
    Yalcin, E.
    Meral, A.
    Sener, B.
    Dogru, D.
    Ozcelik, U.
    Kiper, N.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (04) : 419 - 423
  • [36] Impact of eradication of Pseudomonas aeruginosa on survival in Mexican patients with cystic fibrosis
    Bustamante, Adriana Ester
    Mercado-Longoria, Roberto
    Tijerina-Menchaca, Rolando
    Mas-Trevino, Marcela
    Torres-Rodriguez, Julian
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2014, 66 (04): : 307 - 313
  • [37] MICROBIOLOGICAL FEATURES OF PSEUDOMONAS AERUGINOSA IN CHILDREN WITH CYSTIC FIBROSIS
    Ishchenko, O., V
    Stepanskyi, D. O.
    MEDICNI PERSPEKTIVI, 2021, 26 (03): : 131 - 138
  • [38] Antibody Response to Pseudomonas aeruginosa in Children With Cystic Fibrosis
    Milagres, Lucimar G.
    Castro, Tatiana L. A.
    Garcia, Daniely
    Cruz, Aline C.
    Higa, Laurinda
    Folescu, Tania
    Marques, Elizabeth A.
    PEDIATRIC PULMONOLOGY, 2009, 44 (04) : 392 - 401
  • [39] Phenotypes That Matter: Pseudomonas aeruginosa and Progression of Cystic Fibrosis Lung Disease
    Sanders, Don B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (03) : 245 - 246
  • [40] AN ATYPICAL PSEUDOMONAS AERUGINOSA ASSOCIATED WITH CYSTIC FIBROSIS OF PANCREAS
    DOGGETT, RG
    HARRISON, GM
    STILLWELL, RN
    WALLIS, ES
    JOURNAL OF PEDIATRICS, 1966, 68 (02): : 215 - +